Longitudinal Bmi
Body Mass Index (BMI) is a widely used metric for assessing body fat based on an individual’s height and weight. While a single BMI offers a snapshot of an individual’s weight status at a particular moment, longitudinal BMI involves collecting and analyzing multiple BMI measurements from the same individual over an extended period. This approach provides a dynamic perspective on weight changes throughout the lifespan, offering a more comprehensive understanding than cross-sectional data alone. Studying longitudinal BMI allows researchers and clinicians to track growth patterns, identify periods of rapid weight change, and understand how weight status evolves over time.
Biological Basis
Section titled “Biological Basis”Genetic factors significantly influence an individual’s BMI. Genome-wide association studies (GWAS) have identified numerous genetic loci associated with BMI-related traits.[1] Beyond static measurements, longitudinal genetic studies delve into how these genetic influences manifest and potentially change across different life stages. Research has shown that genetic effects can interact with age and other environmental covariates, shaping an individual’s unique BMI trajectory.[2]For instance, specific single nucleotide polymorphisms (SNPs) have been found to interact with age, leading to varying patterns of BMI change among individuals with different genotypes.[2] Advanced statistical methods, such as linear mixed models, are frequently employed in these studies to analyze repeated measurements and uncover genetic variants that influence growth and weight patterns throughout the lifespan.[3]
Clinical Relevance
Section titled “Clinical Relevance”The trajectory of an individual’s BMI over time holds substantial clinical significance. A consistent change in BMI, particularly a shift from a normal weight to overweight or obese categories, is strongly associated with an increased risk of mortality and various health morbidities.[1]Longitudinal BMI trajectories have been linked to the risk of developing multiple diseases, including various cancers such as prostate, colorectal, esophageal, gastric cardia adenocarcinoma, and lung cancer.[4]Understanding these dynamic patterns, along with their genetic underpinnings, can aid in the early identification of individuals at higher risk for adverse health outcomes. This enables the development of more personalized preventive strategies and timely clinical interventions. For example, analyzing BMI changes in specific patient populations, such as those with gastrointestinal cancer or chronic obstructive pulmonary disease, can offer valuable insights into disease progression and prognosis.[5]
Social Importance
Section titled “Social Importance”The global rise in average BMI, particularly observed in low-income countries, underscores the profound public health challenges posed by obesity and related conditions.[1]Longitudinal studies of BMI are critical for unraveling the intricate interplay between genetic predispositions, environmental factors, and lifestyle choices that collectively shape weight trajectories across diverse populations. By elucidating these complex interactions, including potential gene-environment interactions, researchers can inform the development of targeted public health policies aimed at preventing obesity and mitigating its associated health burdens. This knowledge contributes to creating more effective, population-specific interventions that consider both genetic susceptibility and an individual’s life-course environmental exposures, ultimately fostering healthier societies worldwide.
Methodological and Statistical Challenges
Section titled “Methodological and Statistical Challenges”Studies on longitudinal BMI often face significant methodological and statistical hurdles that can impact the interpretation of findings. A key limitation arises when cohorts designed for longitudinal assessment contain only a single BMI data point per individual, spanning broad age ranges such as 4-11 years or 3-18 years. This constraint fundamentally undermines the ability to accurately capture dynamic changes in BMI over time, making it challenging to draw robust conclusions about longitudinal trajectories and hindering the generalizability or replication of findings. Additionally, cross-sectional analyses within these studies can be affected by extensive multiple testing across numerous age strata, necessitating a cautious approach to interpreting reported associations.[3] Furthermore, the computational demands of advanced statistical models, such as linear mixed models for longitudinal genotype-phenotype associations, often necessitate running analyses on a subset of SNPs, which may lead to an incomplete exploration of the genetic landscape. Analyzing correlated readings from the same individuals, particularly when measurements are taken at close intervals, introduces statistical complexities. While methods like Genomic Control are employed to manage inflation of test statistics, the variability in the number of BMI readings per individual can lead to differential variation in mean BMI values, potentially affecting the consistency and comparability of analytical results.[3]
Generalizability and Phenotype Heterogeneity
Section titled “Generalizability and Phenotype Heterogeneity”The generalizability of findings from longitudinal BMI studies can be limited by the specific ancestral compositions of the cohorts examined. For example, a cohort with a very low mean Native American ancestry (6%) alongside high African and European ancestries may yield genetic associations that are not readily applicable to other populations. Even cohorts with higher, but still admixed, levels of Native American ancestry (e.g., 36%) present challenges in extrapolating results to genetically distinct groups. These population-specific genetic backgrounds mean that identified genetic variants influencing BMI may not have the same effects or prevalence across diverse populations, restricting the broader applicability of the research.[3]Variations in the collection and context of phenotypic data also contribute to heterogeneity and limit interpretation. Factors such as the time of day or season when weight measurements are taken can introduce individual variability, even if such noise is argued not to be systematically associated with genetics. More critically, in studies involving specific health conditions, the timing of BMI measurements relative to disease diagnosis, stage, extent, and treatment protocols (e.g., chemotherapy) can significantly influence observed BMI changes. A lack of detailed clinical information regarding these confounders can obscure the true genetic influences on BMI trajectories, making it difficult to disentangle disease-related effects from underlying genetic predispositions.[1]
Unaccounted Environmental Factors and Heritability Complexities
Section titled “Unaccounted Environmental Factors and Heritability Complexities”Longitudinal BMI is a complex trait influenced by a dynamic interplay of genetic and environmental factors, many of which remain unmeasured or unaccounted for in current studies. Well-known environmental confounders such as smoking status, alongside demographic factors like age, sex, and ethnicity, exert strong influences on BMI, and their comprehensive integration into genetic models is crucial yet challenging. A significant knowledge gap exists in understanding how genetic influences on BMI interact with evolving environmental exposures, particularly nutrition choices, which are often not systematically captured. Future research needs to explore these gene-environment interactions to fully elucidate their impact on BMI trajectories.[2]Furthermore, estimating the heritability of longitudinal BMI presents its own set of complexities, with some methods potentially yielding high estimates that may reflect the substantial contribution of shared environmental factors, epistatic interactions, or dominance effects rather than purely additive genetic variance. This difficulty in precisely partitioning genetic and environmental contributions may contribute to the phenomenon of “missing heritability” for BMI and other complex traits. The limited number of previous genome-wide association studies specifically focused on BMI trajectories further underscores a knowledge gap, impeding a comprehensive understanding of the genetic risk factors that shape BMI changes over an individual’s lifespan.[1]
Variants
Section titled “Variants”Genetic variations play a crucial role in shaping an individual’s body mass index (BMI) trajectory throughout life, with several single nucleotide polymorphisms (SNPs) demonstrating associations with longitudinal changes in BMI. Among the most widely studied is theFTOgene, known as the “fat mass and obesity-associated” gene. The variantrs1558902 in FTO has shown a dynamic effect on BMI across different age groups; specifically, the risk allele was associated with a decrease in BMI during infancy (up to 2 years of age) but subsequently linked to an increase in BMI from 6 years onward, highlighting its complex, age-dependent influence on growth and weight gain.[6] Genetic variations within the FTOlocus are consistently implicated in BMI regulation across diverse populations, suggesting a fundamental role in metabolic processes like appetite control and energy expenditure.[1] These findings underscore the importance of longitudinal studies in capturing the nuanced impact of genetic factors on BMI development from early life into adulthood.
Beyond FTO, other genes and their variants contribute to the intricate genetic architecture of BMI. For instance, variants near DMRT1 (rs445398 ) may influence metabolic pathways, as DMRT1 is a transcription factor, and such regulators can have broad effects on cellular processes, including those impacting energy balance. Similarly, GPC5 (rs2183606 ), encoding a glypican protein, is involved in modulating growth factor signaling, which can affect cell proliferation and tissue development, including adipogenesis, thereby indirectly influencing BMI trajectories.[7] Another example is SLCO5A1 (rs12542317 ), which encodes a solute carrier organic anion transporter. These transporters are vital for the cellular uptake and efflux of various substances, including hormones and nutrients, and variations could alter nutrient metabolism and body weight regulation.[2] Mitochondrial function and lipid metabolism are also key areas where genetic variations can impact BMI. LYRM4 (rs6926791 ) is involved in the assembly of mitochondrial complex I, a critical component of the electron transport chain. Dysregulation of mitochondrial function, potentially influenced by variants like rs6926791 , can lead to altered energy expenditure and increased susceptibility to obesity.[2] Additionally, MOB3B (rs10812580 , rs13283804 ) belongs to a family of proteins that regulate cell growth and differentiation, processes that can affect adipocyte number and size. Variants inBLTP3A (rs3734266 ), a gene potentially involved in lipid processing, may directly influence the breakdown and storage of fats, thereby contributing to variations in BMI over time.
Furthermore, non-coding RNAs and pseudogenes, often in conjunction with nearby functional genes, play regulatory roles in metabolic health. The intergenic variant rs969092 located near LINC02400 and GXYLT1 could affect the expression of GXYLT1, a glycosyltransferase crucial for protein modification, which in turn influences cell signaling and metabolic pathways. Similarly, variants like rs11066997 near the pseudogene GLULP5 and LINC02459, or rs11070771 and rs4775878 associated with GABPB1-AS1 and AHCYP7, may exert their effects through regulatory mechanisms. GABPB1-AS1 is an antisense RNA that could modulate the expression of GABPB1, a gene vital for mitochondrial biogenesis and energy metabolism, thus impacting an individual’s long-term BMI profile.[8]
Key Variants
Section titled “Key Variants”| RS ID | Gene | Related Traits |
|---|---|---|
| rs1421085 rs1558902 | FTO | body mass index obesity energy intake pulse pressure lean body mass |
| rs445398 | DMRT1 | longitudinal bmi |
| rs969092 | LINC02400 - GXYLT1 | longitudinal bmi |
| rs11066997 | GLULP5 - LINC02459 | longitudinal bmi |
| rs2183606 | GPC5 | longitudinal bmi |
| rs11070771 rs4775878 | GABPB1-AS1 - AHCYP7 | longitudinal bmi |
| rs12542317 | SLCO5A1 | longitudinal bmi |
| rs6926791 | LYRM4 | longitudinal bmi |
| rs10812580 rs13283804 | MOB3B | longitudinal bmi |
| rs3734266 | BLTP3A | systemic lupus erythematosus longitudinal bmi memory performance |
Defining Longitudinal Body Mass Index
Section titled “Defining Longitudinal Body Mass Index”Longitudinal BMI refers to the collection of repeated Body Mass Index (BMI) measurements from the same individual over a period, providing a dynamic perspective on an individual’s growth and adiposity changes rather than a single static snapshot. BMI itself is precisely defined as an individual’s weight in kilograms divided by the square of their height in meters (kg/m^2).[1] For longitudinal analyses, operational definitions can vary; researchers may use each individual BMI reading as a separate observation (often termed “BMI-longitudinal”) or calculate the mean of all available BMI readings for an individual (“BMI-mean”).[8]The significance of longitudinal BMI lies in its ability to capture developmental trajectories and changes over time, which are critical for understanding disease risk and health outcomes.[1]Conceptual frameworks for analyzing longitudinal BMI often involve statistical modeling to account for the inherent correlation between repeated measurements from the same person, especially when measurements are taken at frequent intervals.[8] These models, such as linear mixed models, allow for the estimation of individual growth curves and the exploration of factors influencing BMI change over time, including genetic and environmental covariates.[2] The raw BMI values may undergo transformations, such as Box-Cox transformations, to achieve a more normal distribution, and subsequently be standardized into zBMI scores (mean = 0, standard deviation = 1) for consistent analysis across different populations or age groups.[3]
Classification of BMI and Growth Trajectories
Section titled “Classification of BMI and Growth Trajectories”Classification systems for BMI extend beyond single-point measurements to encompass patterns of change over the lifespan. While static BMI values categorize individuals as underweight (<18.5 kg/m^2) or overweight (typically >=25 kg/m^2, though some populations, like those of Asian descent, use a lower threshold of >=23 kg/m^2 due to increased adiposity and health risks at lower BMIs).[1] longitudinal studies focus on “BMI trajectories.” These trajectories describe an individual’s path of BMI change, classifying them into categories such as “Normal BMI,” “Normal to overweight,” “Normal to obese,” or “Overweight to obese”.[4]Such classifications are crucial as changes in BMI over time are strongly associated with increased mortality and morbidity.[1] Specific points within these trajectories are also used for classification and diagnostic criteria, particularly in childhood growth. Key concepts include the Age of Adiposity Rebound (Age-AR), which is the age at which a child’s BMI reaches a minimum after an initial decline and then begins to increase, and the corresponding BMI at Adiposity Rebound (BMI-AR).[9] These growth parameters are derived from modeling BMI changes across defined age windows, such as infancy (2 weeks to 18 months) and childhood (18 months to 13 years).[9]The timing and magnitude of adiposity rebound are significant clinical criteria, as an early Age-AR is linked to a higher risk of obesity in later life.
Terminology and Analytical Approaches
Section titled “Terminology and Analytical Approaches”The terminology associated with longitudinal BMI is integral to its study and interpretation. Besides “BMI-longitudinal” and “BMI-mean,” other critical terms include “zBMI scores,” which represent age- and sex-adjusted BMI values normalized for population comparisons.[3] “Age of Adiposity Rebound” (Age-AR) and “BMI at Adiposity Rebound” (BMI-AR) are specialized terms used to describe specific developmental phases of BMI.[9] Related concepts in growth modeling include “Peak Height Velocity” (PHV) and “Peak Weight Velocity” (PWV), which quantify the maximum rates of growth in height and weight, respectively.[9]Analytical approaches for longitudinal BMI often involve sophisticated statistical models to accurately capture individual variability and trends. Linear mixed models are commonly employed, allowing for the inclusion of both fixed effects (population-level trends) and random effects (individual-level deviations from these trends).[2]Bayesian analysis is another method used to evaluate associations with longitudinal traits, including the detection of gene-environment interactions, such as those between single nucleotide polymorphisms (SNPs) and age.[2] Researchers also acknowledge the importance of validating BMI as a measure of adiposity across different age groups, recognizing that its relationship to fat and fat-free mass can vary by age and sex.[10]
Evolution of Longitudinal BMI Understanding and Methodology
Section titled “Evolution of Longitudinal BMI Understanding and Methodology”Historically, the Body Mass Index (BMI) was primarily evaluated as a single, point-in-time , which led to the identification of approximately 40 genetic loci through early genome-wide association studies (GWAS).[1]However, scientific understanding evolved to recognize that dynamic changes in BMI over time, referred to as “longitudinal BMI,” are significantly associated with increased mortality and morbidity, prompting a critical shift in research focus.[1] Landmark longitudinal studies, such as the Framingham Heart Study (FHS), have been instrumental in this progression, providing extensive population-based data to analyze BMI changes over several decades.[5] This emphasis on longitudinal data spurred the development of specialized analytical techniques, including applied longitudinal analysis.[11] Bayesian analysis for assessing combined genetic effects and interactions with environmental covariates like age.[2] and latent class growth modeling to identify distinct BMI trajectories.[12] Early work on adiposity indices in children.[13] and long-term serial data from studies like the Fels longitudinal growth study.[14] laid foundational understanding for tracking adiposity development from infancy to adulthood and identifying critical periods such as the “adiposity rebound”.[15] This evolution highlights a comprehensive move towards dynamic, life-course approaches in understanding BMI.
Global and Temporal Epidemiology of BMI
Section titled “Global and Temporal Epidemiology of BMI”Over the last three decades, a notable increase in average BMI has been observed globally, particularly in low-income countries.[1] This rise has consequently exposed a larger proportion of these populations to the health risks associated with elevated BMI.[1]Despite this overall increase, significant proportions of the population in regions like Bangladesh and South Asia continue to experience underweight, with one study sample indicating 40% of individuals in this category, a condition also linked to increased mortality from various causes.[1] Longitudinal studies consistently reveal changing BMI patterns over time, demonstrating that an individual’s BMI is not static but follows diverse trajectories influenced by various factors.[4]For instance, analyses of FHS data indicated that while the majority of participants experienced a slight BMI increase, individuals with chronic obstructive pulmonary disease (COPD) showed a more pronounced increase, whereas those with gastrointestinal cancer often experienced an overall decrease in BMI.[5] Understanding these dynamic BMI trajectories across the life course is critical, as they have been linked to the risk of multiple cancers and other adverse health outcomes.[4]
Demographic Influences on BMI Trajectories
Section titled “Demographic Influences on BMI Trajectories”The influence of demographic factors on BMI is substantial and dynamic across the lifespan, with research indicating that genetic associations, such as those involving the LIN28B variant, can show varying effects on BMI depending on the individual’s age.[6] Furthermore, distinct genetic factors are observed to influence BMI during infancy, childhood, and adulthood, underscoring the age-specific nature of growth and adiposity.[9] Beyond genetics, age and sex also influence the validity of BMI as a measure of body fatness, necessitating age- and sex-specific prediction formulas.[16] and the genetic etiology of BMI-related traits may also differ by sex, highlighting the importance of sex-stratified analyses.[1] Ancestry plays a critical role in BMI patterns and genetic predispositions, with studies showing that the genetic etiology of BMI-related traits can vary significantly across different ancestral groups.[1] For example, individuals of Asian descent are recognized to have higher adiposity and associated health risks at lower BMI thresholds compared to those of European descent, leading to the adoption of different BMI cutoffs for overweight classification in some populations.[1] Genome-wide association studies have expanded to include diverse populations, such as Australian Aboriginal populations.[8] and admixed children with Native American and European ancestry.[3]to better understand these population-specific genetic architectures and account for family and ethnic variation in longitudinal BMI analyses.[7]
Biological Background of Longitudinal BMI
Section titled “Biological Background of Longitudinal BMI”Body Mass Index (BMI) is a widely used measure to assess body fat based on an individual’s weight and height. While a single BMI provides a snapshot, longitudinal BMI analysis, which tracks changes over time, offers critical insights into an individual’s health trajectory and associated biological mechanisms. This dynamic perspective reveals how genetic predispositions, molecular processes, and environmental factors interact to influence weight status throughout life.
Genetic Influences on BMI Trajectories
Section titled “Genetic Influences on BMI Trajectories”Genetics significantly influences an individual’s Body Mass Index (BMI) and its changes over time. Genome-wide association studies (GWAS) have identified numerous genetic loci associated with BMI-related phenotypes.[1]These studies indicate that specific genetic variants contribute to the heritability of BMI, with estimates for complex traits like lung cancer (which can be influenced by BMI) ranging from 12–21%.[4]The identification of novel single nucleotide polymorphisms (SNPs) associated with longitudinal obesity-related traits further emphasizes the dynamic interplay of genetics in shaping BMI trajectories throughout life.[2] Genetic mechanisms extend beyond simple associations to include interactions with environmental factors, such as nutrition, where different genetic variants may influence BMI differently based on dietary choices.[1] Functional annotation of identified loci often involves pinpointing candidate genes through analysis of cis-expression quantitative trait loci (cis-eQTLs), which reveal how genetic variants can regulate gene expression patterns in relevant tissues.[4] For example, a variant in the LIN28B gene has been linked to pubertal timing and demonstrates varying associations with BMI across different life stages, highlighting the role of specific genes in developmental processes that impact BMI.[6]
Molecular and Cellular Basis of BMI Regulation
Section titled “Molecular and Cellular Basis of BMI Regulation”The regulation of BMI at the molecular and cellular level involves complex metabolic processes and signaling pathways that govern energy balance and adiposity. While specific pathways are not extensively detailed in all contexts, research aims to explore the potential molecular roles of genetically identified loci.[4] This includes understanding how critical proteins, enzymes, and other biomolecules, whose expression or function may be altered by genetic variants, contribute to cellular functions underlying weight regulation.
Genes such as DOCK1(Dedicator of Cytokinesis 1) have been associated with changes in BMI in the context of diseases like gastrointestinal cancer and chronic obstructive pulmonary disease.[5] This suggests DOCK1’s involvement in cellular processes that impact metabolic health or tissue integrity, which in turn can influence BMI dynamics. Similarly, the LIN28B gene, implicated in pubertal timing, likely plays a role in developmental signaling pathways that modulate growth and metabolism, thereby affecting an individual’s BMI trajectory from early life through adulthood.[6] These molecular insights, derived from genetic studies, provide a foundation for understanding the intricate cellular functions that contribute to BMI variation.
Developmental and Pathophysiological Dynamics of BMI
Section titled “Developmental and Pathophysiological Dynamics of BMI”Body Mass Index is not a static measure but a dynamic trait influenced by developmental processes and subject to pathophysiological disruptions throughout the lifespan. Studies often analyze BMI across early life and childhood, recognizing that early-life trajectories can set the stage for later health outcomes.[6]Changes in BMI over time are significantly associated with increased mortality and morbidity, emphasizing the importance of longitudinal perspectives in health assessment.[1]Pathophysiological processes linked to BMI include its association with a heightened risk of various diseases. For instance, a trajectory from normal weight to obesity is connected to an increased risk of multiple cancers, including prostate, colorectal, esophageal, gastric cardia adenocarcinoma, and lung cancer.[4]Conversely, low BMI is also associated with increased mortality from a wide range of causes, such as cardiovascular disease, cancer, and respiratory disease.[1]These systemic consequences underscore how disruptions in homeostatic processes related to energy balance, whether leading to underweight or overweight, manifest as significant health burdens across different organ systems and contribute to overall disease mechanisms.
Prognostic Insights and Risk Stratification
Section titled “Prognostic Insights and Risk Stratification”Longitudinal body mass index (BMI) provides critical prognostic information beyond single-point assessments, offering a dynamic view of an individual’s health trajectory. Both high and low BMI are associated with increased mortality and poor health outcomes, and importantly, a change in BMI over time further elevates the risk of morbidity and mortality.[1]For instance, specific BMI trajectories, such as a shift from normal weight to overweight or obese, are linked to an increased risk for various cancers, including non-small cell lung cancer (NSCLC), prostate, colorectal, esophageal, and gastric cardia adenocarcinoma.[4] This ability to track BMI patterns allows clinicians to identify high-risk individuals earlier, facilitating personalized prevention strategies and timely interventions.
Understanding these trajectories is crucial for risk stratification, where individuals can be categorized based on their evolving BMI patterns and associated health risks. For example, in studies involving older populations, changes in BMI, rather than static values, have been found to be associated with genetic variants and specific disease states like gastrointestinal cancer and chronic obstructive pulmonary disease (COPD).[5] Recognizing these dynamic changes enables a more nuanced risk assessment, moving towards precision medicine where interventions are tailored to an individual’s unique BMI progression and their underlying genetic predispositions, which may vary by ancestry, sex, and environmental factors.[1]
Diagnostic Utility and Guiding Clinical Management
Section titled “Diagnostic Utility and Guiding Clinical Management”The analysis of longitudinal BMI offers significant diagnostic utility and directly informs clinical management strategies. By tracking BMI over time, healthcare providers can gain deeper insights into disease progression and treatment response, especially in conditions where weight fluctuations are indicative of health status. For instance, in individuals with cancer or COPD, monitoring the change in BMI (ΔBMI) can reveal important clinical signals, with distinct patterns observed; for example, gastrointestinal cancer patients may exhibit a median BMI loss, while COPD patients might show a slight increase.[5] This detailed understanding helps in assessing the severity of the condition and the effectiveness of therapeutic interventions.
Furthermore, longitudinal BMI data, often analyzed using advanced statistical methods like linear mixed models or latent class growth models, can help in identifying specific genetic associations with growth traits and disease risk.[3] Such analyses allow for the detection of genetic variants that interact with environmental covariates, including age, influencing BMI trajectories.[2]This integration of genetic insights with BMI trajectories can guide treatment selection, particularly in complex diseases like NSCLC, where genetic risk factors may modulate the impact of BMI patterns on disease susceptibility.[4] Ultimately, this approach supports the development of more effective monitoring protocols and targeted therapies based on an individual’s unique physiological and genetic profile.
Elucidating Comorbidity Links and Phenotypic Overlaps
Section titled “Elucidating Comorbidity Links and Phenotypic Overlaps”Longitudinal BMI analysis is instrumental in uncovering complex associations with comorbidities and understanding overlapping phenotypes across diverse patient populations. Tracking BMI changes over the life course reveals its intricate relationship with various health conditions, highlighting that genetic factors influencing BMI can also impact the risk of related diseases. For example, genome-wide association studies (GWAS) in specific populations, such as Australian Aboriginal individuals, have identified genetic risk factors for BMI that are also linked to type 2 diabetes, demonstrating how longitudinal BMI can serve as a marker for metabolic health.[8]This approach provides a clearer picture of how genetic and environmental factors contribute to disease susceptibility.
Moreover, the genetic etiology of BMI-related traits can differ significantly across ancestries, sexes, and environments, emphasizing the need for population-specific studies to fully understand disease risk.[1]In populations like Bangladeshi adults, where both underweight and overweight are prevalent, longitudinal BMI analysis helps to clarify the distinct risks associated with different BMI categories and their changes over time, including increased mortality from cardiovascular disease, cancer, and respiratory disease.[1] By leveraging longitudinal data, clinicians can better appreciate the syndromic presentations and interconnectedness of conditions, leading to more comprehensive management strategies that address the full spectrum of an individual’s health risks and comorbidities.
Longitudinal Cohort Studies and Temporal BMI Patterns
Section titled “Longitudinal Cohort Studies and Temporal BMI Patterns”Longitudinal studies are crucial for understanding the dynamics of Body Mass Index (BMI) over time within populations. The Framingham Heart Study (FHS), a long-standing population-based cohort, has provided insights into BMI changes in individuals over 40 years, revealing that while most participants experienced a slight BMI increase over 7-9 years, specific health conditions present distinct temporal patterns. For instance, the Chronic Obstructive Pulmonary Disease (COPD) population showed the highest median BMI increase, whereas the gastrointestinal cancer population uniquely experienced an overall median BMI loss.[5]Similarly, the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial employed latent class growth modeling to identify distinct BMI trajectories across different age points (e.g., 20, 50, and baseline), demonstrating how BMI patterns evolve throughout adulthood and their potential associations with disease risks.[4]The Korea Association Resource (KARE) cohort also utilized advanced Bayesian mixed models to analyze longitudinal obesity-related traits, enhancing the detection of genetic factors and their interactions with age over time.[2]These large-scale cohort investigations often involve sophisticated methodologies to capture and analyze longitudinal data. The National Longitudinal Study of Adolescent to Adult Health (Add Health) leveraged extensive genome-wide information from sibling pairs to conduct weighted genome-wide association studies (GWAS) of longitudinal BMI, accounting for complex factors like family and ethnic variation.[17]In the context of an Australian Aboriginal population, longitudinal BMI data was analyzed by fitting sex-specific polynomial curves across age, which significantly improved the fit compared to a single curve, highlighting the importance of nuanced modeling for diverse populations.[8] Such studies typically involve repeated BMI observations, sometimes several years apart, and utilize statistical approaches like standardized residuals from fitted curves or modeling correlations between repeated readings to accurately assess changes and associations.[8]
Cross-Population and Ancestry-Specific Insights
Section titled “Cross-Population and Ancestry-Specific Insights”Understanding longitudinal BMI dynamics necessitates cross-population comparisons and an appreciation for ancestry-specific variations. The Add Health study, for instance, specifically designed its longitudinal BMI GWAS to account for both family and ethnic variation, incorporating genetic ancestry estimates from diverse geographical origins including Europe, West Africa, and various parts of Asia and the Americas.[17]This approach allows for a more comprehensive understanding of BMI’s genetic architecture across different ancestral backgrounds. Research on admixed children with Native American and European ancestry further underscores the importance of these considerations, by evaluating how both local and global ancestry influence longitudinal BMI-related growth traits in GWAS analyses.[3] Such studies reveal that the genetic underpinnings of BMI can indeed vary significantly across diverse populations, influencing how genetic risk factors are identified and interpreted.
Population-specific epidemiological findings also highlight critical differences in BMI interpretation and health risk. In an Australian Aboriginal population, a BMI greater than 22 kg/m2 was identified as a significant risk factor for Type 2 Diabetes, a threshold lower than that typically applied in populations of European descent.[8] This finding aligns with observations in Bangladeshi adults, where a BMI cutoff of 23 kg/m2 was used to classify overweight status, recognizing that people of Asian descent may exhibit higher adiposity and associated comorbidities at lower BMI values.[1] These distinctions emphasize that generalizations about BMI-related health risks must be made cautiously, as the genetic etiology of BMI-related traits, their prevalence patterns, and their health implications can differ substantially based on ancestry, sex, and environmental context.[1]
Epidemiological Associations and Genetic Correlates of BMI Trajectories
Section titled “Epidemiological Associations and Genetic Correlates of BMI Trajectories”Longitudinal BMI studies have elucidated significant epidemiological associations between BMI trajectories and various health outcomes, alongside demographic and socioeconomic correlates. For example, in the PLCO study, specific BMI trajectories were found to be associated with the risk of non-small cell lung cancer (NSCLC), even after adjusting for critical demographic factors like age, sex, race, education, and lifestyle factors such as smoking and personal history of diabetes.[4]Beyond cancer, the broader epidemiological landscape reveals that both overweight and underweight individuals face an increased risk of mortality and adverse health outcomes compared to those with a normal BMI.[1]Research in Bangladeshi adults and other Asian cohorts further highlights that a change in BMI over time is linked to increased mortality and morbidity, with low BMI specifically associated with higher mortality from cardiovascular disease, cancer, and respiratory disease.[1]Genome-wide association studies (GWAS) are increasingly employed to uncover the genetic correlates of longitudinal BMI and its changes. In the FHS cohort, an association was identified between changes in BMI and theDedicator of Cytokinesis 1 (DOCK1) gene, particularly in individuals with gastrointestinal cancer and chronic obstructive pulmonary disease.[5]The KARE cohort, utilizing advanced Bayesian methods, successfully identified novel single nucleotide polymorphisms (SNPs) associated with longitudinal obesity-related traits and detected significant SNP-time interactions, demonstrating the enhanced power of these models for complex longitudinal data.[2] Associations between a pubertal timing-related variant in LIN28B and BMI are also noted to vary across the life course.[6] Methodologically, these studies often involve large sample sizes, such as the 1,888 individuals in the Add Health sibling pairs subsample or the 361 genotyped individuals in the Australian Aboriginal study, and employ rigorous quality control measures and statistical adjustments for factors like kinship and population structure to ensure representativeness and generalizability of findings.[17]
Frequently Asked Questions About Longitudinal Bmi
Section titled “Frequently Asked Questions About Longitudinal Bmi”These questions address the most important and specific aspects of longitudinal bmi based on current genetic research.
1. Why do some people never gain weight no matter what they eat?
Section titled “1. Why do some people never gain weight no matter what they eat?”Your genetics play a significant role in how your body processes food and stores energy. Some individuals are born with genetic predispositions that make them naturally less prone to weight gain, even when consuming similar amounts of food as others. Genome-wide association studies have identified many genetic regions linked to BMI-related traits that influence this variability.
2. Does stress actually cause weight gain or is that a myth?
Section titled “2. Does stress actually cause weight gain or is that a myth?”Yes, environmental factors like stress can interact with your genetic makeup to influence your weight trajectory over time. Your unique genetic predispositions might make you more susceptible to gaining weight during periods of high stress, as these interactions shape how your body responds to various life circumstances.
3. My sibling is thin but I’m not – why the difference?
Section titled “3. My sibling is thin but I’m not – why the difference?”Even though you share family genetics, you and your sibling inherited different combinations of genetic variants that influence BMI. These distinct genetic profiles, combined with individual lifestyle choices and environmental exposures, can lead to very different weight patterns and health outcomes throughout your lives.
4. Is it true that metabolism slows down as you age?
Section titled “4. Is it true that metabolism slows down as you age?”Yes, your genetics can interact with age to influence how your body changes over time, including metabolic rate. Specific genetic variations have been found to lead to varying patterns of BMI change as individuals get older, contributing to the common observation that metabolism can shift with age.
5. Why do weight loss diets work for others but not me?
Section titled “5. Why do weight loss diets work for others but not me?”Your unique genetic makeup significantly influences how your body responds to different diets and exercise regimens. What is effective for one person might not yield the same results for you due to your specific genetic predispositions, highlighting the importance of personalized approaches to weight management.
6. I’m [ethnicity] – does my background affect my weight risk?
Section titled “6. I’m [ethnicity] – does my background affect my weight risk?”Yes, your ancestral background can influence your genetic risk for certain weight trajectories. Research shows that genetic variants affecting BMI can have different effects and prevalence across diverse populations, meaning your ethnicity can play a role in your individual susceptibility to weight changes.
7. Can exercise really overcome bad family history?
Section titled “7. Can exercise really overcome bad family history?”While genetics provide a predisposition, lifestyle choices like consistent exercise are powerful environmental factors that interact with your genes. Regular physical activity can significantly influence your BMI trajectory, potentially mitigating some of the genetic risks you might have inherited from your family.
8. Why can’t I lose weight even when my friend eats less than me?
Section titled “8. Why can’t I lose weight even when my friend eats less than me?”Your body’s response to food intake and energy expenditure is highly individual and influenced by your genetics. You might have genetic variations that affect your metabolism or how your body stores fat differently compared to your friend, even with similar eating habits.
9. Does staying up late make me gain weight?
Section titled “9. Does staying up late make me gain weight?”Environmental factors, such as your sleep schedule, can interact with your genetic predispositions to influence your weight over time. While the direct genetic link isn’t always simple, disruptions to sleep can impact hormones and behaviors that, in combination with your unique genetics, might contribute to weight gain.
10. Is a DNA test actually worth it for my weight problems?
Section titled “10. Is a DNA test actually worth it for my weight problems?”A DNA test can offer insights into your genetic predispositions for certain BMI trajectories and weight-related risks. This information can contribute to developing more personalized preventive strategies and timely interventions, helping you understand your individual risk factors and potentially guiding more effective approaches to health.
This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.
Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.
References
Section titled “References”[1] Scannell Bryan M et al. “Genome-wide association studies and heritability estimates of body mass index related phenotypes in Bangladeshi adults.”PLoS One, vol. 9, no. 8, 2014, p. e105025.
[2] Chung, W et al. “Bayesian analysis of longitudinal traits in the Korea Association Resource (KARE) cohort.” Genomics Inform, 2022.
[3] Vicuna, L et al. “New insights from GWAS on BMI-related growth traits in a longitudinal cohort of admixed children with Native American and European ancestry.” iScience, 2023.
[4] You, D et al. “Associations of genetic risk, BMI trajectories, and the risk of non-small cell lung cancer: a population-based cohort study.”BMC Med, 2022.
[5] McDonald, M. N., et al. “Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.”J Cachexia Sarcopenia Muscle, 2017.
[6] Warrington, N. M., et al. “A genome-wide association study of body mass index across early life and childhood.”Int J Epidemiol, 2015.
[7] McQueen, MB et al. “The National Longitudinal Study of Adolescent to Adult Health (Add Health) sibling pairs genome-wide data.” Behav Genet, 2015.
[8] Anderson, D et al. “First genome-wide association study in an Australian aboriginal population provides insights into genetic risk factors for body mass index and type 2 diabetes.”PLoS One, 2015.
[9] Couto Alves, A. et al. “GWAS on longitudinal growth traits reveals different genetic factors influencing infant, child, and adult BMI.” Sci Adv, 2019.
[10] Bell, K. A. et al. “Validity of body mass index as a measure of adiposity in infancy.”J Pediatr, 2018.
[11] Fitzmaurice, G. M., N. M. Laird, and J. H. Ware. Applied Longitudinal Analysis. Wiley, 2011.
[12] Koning, M., et al. “Identifying developmental trajectories of body mass index in childhood using latent class growth (mixture) modelling: associations with dietary, sedentary and physical activity behaviors: a longitudinal study.”BMC Public Health, vol. 16, no. 1, 2016, p. 1128.
[13] Rolland-Cachera, M. F., et al. “Adiposity indices in children.” Am J Clin Nutr, vol. 36, 1982, pp. 178–84.
[14] Siervogel, R. M., et al. “Patterns of change in weight/stature2 from 2 to 18 years: Findings from long-term serial data for children in the Fels longitudinal growth study.” Int J Obes, vol. 15, 1991, pp. 479–485.
[15] Williams, S. M., and A. Goulding. “Patterns of growth associated with the timing of adiposity rebound.” Obesity, vol. 17, 2009, pp. 335–341.
[16] Deurenberg, P., J. A. Weststrate, and J. C. Seidell. “Body mass index as a measure of body fatness: Age- and sex-specific prediction formulas.”Br J Nutr, 1991.
[17] McQueen, M. B. “The National Longitudinal Study of Adolescent to Adult Health (Add Health) sibling pairs genome-wide data.” Behav Genet, 2014.